News & Insights
Welcome to Bellberry’s blog. Here we publish commentary, updates, feature posts, and thought leadership on research ethics, regulation, participant experience, and system change. Discover what’s happening across the research and ethics landscape in Australia and beyond.
Bellberry CEO joins ARCS COVID-19 Webinar
Earlier this week Bellberry CEO Kylie Sproston joined Tam Nguyen (St Vincent’s Hospital Melbourne) and James Cokayne (NSW Health) to speak at one of ARCS Australia’s series of webinars on COVID-19. The session was entitled ‘Ethics Committees and Governance’ and topics discussed by the panel included how to manage the continuation of the safety and […]
Read More
PRAXIS Australia free webinar series: Resilience in the era of COVID-19
ENROL NOW! PRAXIS’s small team has received over 1000 enrolments for these sessions and as such processing of registrations may be prolonged. It’s likely that PRAXIS will need to plan new dates so please visit the PRAXIS website regularly!
Read More
COVID-19: Bellberry Planning and Services
Bellberry has been monitoring the development of the COVID-19 outbreak over the last few weeks. As the Australian situation has now moved past the 100 patient point, we would like to share with you information about our planning and services. Research Participant Welfare & Study Changes As the COVID-19 situation escalates in a number of […]
Read More
COVID-19 and Clinical Trials
Research Participant Welfare & Study Changes As the COVID-19 situation escalates in a number of jurisdictions around the world and within Australia, many Clinical Trial Sites and Sponsors are considering actions to be taken to protect the welfare of trial Participants, and to support the continuation of on-going trials. The following are suggested topics for […]
Read More
Four new HREC’s!
Bellberry is delighted to announce the recent registration and certification of 4 new HRECs H, I, J and K bringing our total number of HRECs to 12. This enables us to support up to 3 HREC meetings per week. Full details of all our Committee’s can be found on our HREC page.
Read More
Bellberry welcome new staff
Early last year Bellberry adopted the Early Phase Clinical Trial (EPCT) reviews for NSW public health sites and during that time submissions have steadily grown. To enable us to support this growth along with organic business growth, we are delighted to announce that we have recently recruited additional staff. Joining the administration team we […]
Read More
PRAXIS CEO shortlisted for Impact 25 Awards: Vote before Thursday!
Melanie Gentgall, CEO of Praxis Australia, has been shortlisted for Pro Bono Australia’s Impact 25 awards. These awards seek to recognise and celebrate the amazing people delivering incredible outcomes in the Not For Profit sector. Through Praxis, Bellberry seeks to support education that in turn delivers on our core objectives of improving the quality, efficiency […]
Read More
Bellberry 2020: What’s New?
Bellberry’s mission is to protect the welfare of research participants and to improve the quality, efficiency and effectiveness of research. Whenever possible, we are always striving to make improvements to streamline the HREC process. To kick off in 2020, please find below an update of the significant changes that will impact research sites and sponsors. […]
Read More
NSW Early Phase Clinical Trials reach 50 Submissions!
As we entered 2020 Bellberry celebrated the New Year by reaching our 50th submission for NSW Health Early Phase Clinical Trials. Bellberry HRECs were appointed by NSW Health for the review of adult Early Phase Clinical Trial (EPCT) applications early in 2019. From April 2019, all EPCT HREC trials conducted at an NSW Public Health […]
Read More
Christmas and New Year 2019/20
The Bellberry office will be closed from Tues 24 Dec at 5 pm until Thurs 2 Jan at 9 am. There will be no HREC meeting on Wed 1 Jan 2020 (public holiday). The first meeting of 2020 is on Thurs 2 Jan. All remaining HREC meetings for 2020 will be held weekly every Wednesday.
Read More
New Staff Positions at Bellberry
Due to the recent addition of Early Phase Clinical Trial (EPCT) reviews for NSW public health sites, organic business growth and in preparation for future growth, Bellberry has recently externally advertised and recruited to a number of new roles, several of which have been successfully filled internally. Member Coordinator Congratulations to HREC Administrator Molly Wundenburg […]
Read More
New HREC Officers
Due to the recent addition of Early Phase Clinical Trial (EPCT) reviews for NSW public health sites, organic business growth and in preparation for future growth, Bellberry has recently advertised and recruited to a number of new roles including new HREC Officers. Bellberry is delighted to announce that four new HREC Officers have recently joined […]
Read More
CT:IQ Projects Update
Two of five of our 2019 projects are now in the launch phase or complete: Project 1:Â Consumer Involvement and Engagement The Toolkit was launched at the ACTA International Conference on 4-October!! The Toolkit is a joint initiative between Australian Clinical Trials Alliance (ACTA) and Clinical Trials: Quality & Impact (CT:IQ) providing practical advice for […]
Read More
ASCEPT-PAGANZ 2019 Joint Scientific Meeting
25 – 29 November, Queenstown, NZ ‘Shared horizons: Optimising drug response to improve patient outcomes’ The Meeting offers the opportunity to network with colleagues and other leading international and national scientists and academics at both social and scientific activities. A key feature of the Meeting is the chance for early career researchers and research students […]
Read More
Human Research Ethics Committees
Discover how Bellberry's committees operate and maintain the highest ethical standards in research.
Learn More
Monitoring & Quality
Learn about Bellberry's continuous improvement and oversight processes that ensure accountability.
Learn More
Grant Activities
See how Bellberry reinvests in research education and participant-focused initiatives.
Learn More